Additionally, salivary IL-1β levels have been observed to be higher in RA patients, especially in those without anti-TNF-α therapy, suggesting that salivary cytokine levels may also be associated with the response to RA therapies [94]. Here, IL1B is linked to rheumatoid arthritis.